Web Stats Provided By Google Analytics

Friday, February 14, 2014

FDA approves Vimizim to treat rare congenital enzyme disorder

The U.S. Food and Drug Administration today approved Vimizim , the first FDA-approved treatment for Mucopolysaccharidosis Type IVA .

http://ift.tt/1cFMsNW

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts